Search
for
Sort by
Research 91–120 of 1000+
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Liposomes with an Ethanol Fraction as an Application for Drug Delivery
- INTERFERONS IN DERMATOLOGY
- Failure to induce alopecia areata in C3H/HeJ mice with exogenous interferon gamma
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Drug Repositioning: New Opportunities for Older Drugs
- Chapter 14 Principles of drug metabolism
- Liposome-based drug delivery systems for skin wound healing: a promising drug delivery strategy
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis
- Cutaneous drug reactions
- Niosomes as a propitious carrier for topical drug delivery
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- In Vivo Evaluation of<i>Eclipta alba</i>Extract as Anticancer and Multidrug Resistance Reversal Agent
- Pharmacology of Induced Artificial Platelets in Regenerative Medicine: Beyond Transfusion
- Dissolving microneedles: an advanced approach for transdermal drug delivery
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Atypical Case of Minoxidil-Induced Generalized Anasarca and Pleuropericardial Effusion
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- The PDGF/PDGFR pathway as a drug target
- Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Nanomilled Oral Testosterone Plus Dutasteride Effectively Normalizes Serum Testosterone in Normal Men With Induced Hypogonadism
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C